Expressing optimism that a vaccine for COVID-19 would be developed by October-November this year, Adar Poonawalla, CEO of Serum Institute of India, the world’s largest vaccine manufacturer by volume on July 22, said that the institute plans to produce one billion doses of the vaccine over the coming year.
“In India, the next phase trial will start in mid-August and the vaccine will be ready by October-November this year,” said Poonawalla. “We will be going for large scale manufacturing in mid-August-early-August… By the end of this year, we should be able to produce 3 to 4 million doses come the end of December. That’s the target and I hope we can do that,” he added.
Collaborated with biopharmaceutical company AstraZeneca to manufacture the experimental COVID-19 vaccine candidate developed by the University of Oxford, the institute has been given a nod from the Drug Controller General of India (DCGI) to manufacture its indigenously developed pneumococcal vaccine.